Abou-Issa H, Dwivedi C, Curley R W, Kirkpatrick R, Koolemans-Beynen A, Engineer F N, Humphries K A, el-Masry W, Webb T E
Department of Surgery, Ohio State University, Columbus 43210.
Anticancer Res. 1993 Mar-Apr;13(2):395-9.
The biochemical basis for the cancer chemopreventive and anti-cancer activities of glucarate, retinoids (13-cis-retinoic acid, hydroxyphenyl retinamide) and their synergistic combination, has been evaluated. Neither alone nor in combination did these agents affect the level in the rat, of enzymes which are (a) known to correlate with reduced risk of carcinogenesis (detoxification enzyme, catalase, glutathione reductase) nor (b) enzymes which correlate with increased risk of carcinogenesis (beta-glucuronidase, xanthine oxidase, glucose-6-phosphate dehydrogenase). Retinoids, but neither glucarate nor its lactone inhibited free radical-induced lipid peroxidation. Both agents alone and synergistically in combination, raise cellular cAMP levels, repress protein kinase C and more generally inhibited DNA synthesis.
已对葡糖二酸、类视黄醇(13-顺式视黄酸、羟苯基视黄酰胺)及其协同组合的癌症化学预防和抗癌活性的生化基础进行了评估。这些药剂单独使用或联合使用时,均未影响大鼠体内以下两类酶的水平:(a) 已知与降低致癌风险相关的酶(解毒酶、过氧化氢酶、谷胱甘肽还原酶),以及 (b) 与增加致癌风险相关的酶(β-葡萄糖醛酸酶、黄嘌呤氧化酶、葡萄糖-6-磷酸脱氢酶)。类视黄醇可抑制自由基诱导的脂质过氧化,但葡糖二酸及其内酯均无此作用。单独使用这两种药剂以及协同组合使用时,均可提高细胞内cAMP水平,抑制蛋白激酶C,并更广泛地抑制DNA合成。